Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

NCT00219817 is registered in ClinicalTrials.gov with Helsinn Therapeutics (U.S.), Inc as lead sponsor.

NCT NCT00219817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00219817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
Lead sponsor
Helsinn Therapeutics (U.S.), Inc
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
October 31, 2006
Enrollment
80
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cancer cachexia